{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:08:11Z","timestamp":1762456091148,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ebiom.2020.102856","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T08:43:49Z","timestamp":1593765829000},"page":"102856","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Connexin hemichannel inhibition improves skin pathology in Clouston syndrome mice"],"prefix":"10.1016","volume":"57","author":[{"given":"Roberto","family":"Bruzzone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3285-7434","authenticated-orcid":false,"given":"Thomas W.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2020.102856_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102825","article-title":"A potent antagonist antibody targeting connexin hemichannels alleviates Clouston syndrome symptoms in mutant mice","author":"Kuang","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2020.102856_bib0002","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.semcdb.2015.11.018","article-title":"Connexin channels in congenital skin disorders","volume":"50","author":"Lilly","year":"2016","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102856_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-1033.1996.0001q.x","article-title":"Connections with connexins: the molecular basis of direct intercellular signaling","volume":"238","author":"Bruzzone","year":"1996","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.ebiom.2020.102856_bib0004","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.neuropharm.2013.03.020","article-title":"Connexin channel modulators and their mechanisms of action","volume":"75","author":"Verselis","year":"2013","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.ebiom.2020.102856_bib0005","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nrd.2018.138","article-title":"Therapeutic strategies targeting connexins","volume":"17","author":"Laird","year":"2018","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102856_bib0006","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jid.2015.11.017","article-title":"From Hyperactive Connexin26 hemichannels to impairments in epidermal calcium gradient and permeability barrier in the keratitis-ichthyosis-deafness syndrome","volume":"136","author":"Garcia","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ebiom.2020.102856_bib0007","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3389\/fnmol.2017.00298","article-title":"Design and Characterization of a human monoclonal antibody that modulates mutant Connexin 26 hemichannels implicated in deafness and skin disorders","volume":"10","author":"Xu","year":"2017","journal-title":"Front Mol Neurosci"},{"issue":"9","key":"10.1016\/j.ebiom.2020.102856_bib0008","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.febslet.2014.03.040","article-title":"The Clouston syndrome mutation connexin30 A88V leads to hyperproliferation of sebaceous glands and hearing impairments in mice","volume":"588","author":"Bosen","year":"2014","journal-title":"FEBS Lett"},{"issue":"16","key":"10.1016\/j.ebiom.2020.102856_bib0009","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/hmg\/ddh191","article-title":"Connexin30 mutations responsible for hidrotic ectodermal dysplasia cause abnormal hemichannel activity","volume":"13","author":"Essenfelder","year":"2004","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102856_bib0010","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/hmg\/ddx386","article-title":"Cx32 hemichannel opening by cytosolic Ca2+ is inhibited by the R220X mutation that causes Charcot-Marie-Tooth disease","volume":"27","author":"Carrer","year":"2018","journal-title":"Hum Mol Genet"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420302310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420302310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:01:27Z","timestamp":1762455687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396420302310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":10,"alternative-id":["S2352396420302310"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102856","relation":{},"ISSN":["2352-3964"],"issn-type":[{"type":"print","value":"2352-3964"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Connexin hemichannel inhibition improves skin pathology in Clouston syndrome mice","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102856","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102825","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102856"}}